查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514143

全球電腦輔助檢測 (CAD) 市場

Computer Aided Detection (CAD)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 203 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球電腦輔助偵測 (CAD) 市場預計將達到 20 億美元

全球電腦輔助檢測 (CAD) 市場預計到 2023 年將達到 11 億美元，預計在 2023 年至 2030 年分析期間將以 9.1% 的複合年成長率成長，並在 2030 年達到 20 億美元。乳房X光攝影模式是本報告分析的細分市場之一，預計複合年成長率為9.8%，到分析期結束時將達到7.59億美元。在分析期間，MRI 成像領域的複合年成長率估計為 8.6%。

美國市場預估為2.845億美元，中國預期複合年成長率為12.3%

預計 2023 年美國電腦輔助偵測 (CAD) 市場規模將達到 2.845 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達到4.58億美元，2023-2030年分析期間複合年成長率為12.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 5.8% 和 7.3%。在歐洲，德國的複合年成長率預計約為 6.8%。

全球電腦輔助檢測 (CAD) 市場 - 主要趨勢和促進因素總結

由先進演算法和機器學習支援的電腦輔助檢測（CAD）系統在解釋醫學影像和提高各個醫學領域的診斷準確性方面發揮著重要作用。這些系統可幫助放射科醫師從 X 光、MRI、內視鏡檢查和超音波等影像中識別潛在的異常，從而提供關鍵的診斷支援。隨著人工智慧等先進技術的融合，CAD系統在數位病理、預防篩檢、急診診斷等領域變得越來越不可或缺。對這些系統不斷成長的需求是因為它們能夠透過支持早期檢測和準確診斷來改善患者的治療結果，特別是在癌症等複雜領域。

乳房X光攝影和 MRI 等醫學影像處理技術的進步，加上癌症盛行率的上升，是 CAD 市場的主要促進因素。這些改進帶來更精確、更高解析度的影像，使 CAD 軟體能夠執行更準確的分析。此外，醫療保健領域向雲端運算的轉變使得可擴展且可存取的 CAD 解決方案的開發成為可能，從而降低 IT 成本並增強醫療保健專業人員之間的協作。多重模式CAD 系統可以分析來自各種診斷儀器的影像，這一趨勢將進一步提高診斷準確性和患者治療效果。

AI 與 CAD 系統的整合代表了醫學影像領域的重大發展，它提供了從大量資料集學習並識別表明癌症等疾病的複雜模式和異常的工具。人工智慧的這種整合正在加速診斷，減少人為錯誤，並專注於預防性醫療保健和早期診斷。除了一般的診斷影像之外，CAD 系統在疾病檢測方面也找到了專門的應用，例如大腸鏡檢查中的息肉和呼吸系統醫學中的肺結節。正在進行的研究表明，CAD 創新也正在進入數位病理學領域，將其應用擴展到更廣泛的診斷任務，包括標準 H&E 染色以及免疫染色的分析。

調查企業舉例（共103家）

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-6036

Global Computer Aided Detection (CAD) Market to Reach US$2.0 Billion by 2030

The global market for Computer Aided Detection (CAD) estimated at US$1.1 Billion in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. Mammography Modality, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$759.0 Million by the end of the analysis period. Growth in the MRI Modality segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$284.5 Million While China is Forecast to Grow at 12.3% CAGR

The Computer Aided Detection (CAD) market in the U.S. is estimated at US$284.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$458.0 Million by the year 2030 trailing a CAGR of 12.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.8% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Computer Aided Detection (CAD) Market - Key Trends and Drivers Summarized

Computer-Aided Detection (CAD) systems, utilizing advanced algorithms and machine learning, play a crucial role in interpreting medical images and enhancing diagnostic accuracy across various medical fields. These systems assist radiologists by identifying potential abnormalities in images from X-rays, MRIs, endoscopies, and ultrasounds, providing vital diagnostic support. With the integration of sophisticated technologies such as artificial intelligence, CAD systems are becoming increasingly vital in fields like digital pathology, preventive screenings, and emergency diagnostics. The growing demand for these systems is driven by their ability to improve patient outcomes by supporting early detection and accurate diagnosis, particularly in complex areas such as cancer.

Technological advancements in medical imaging technologies such as mammography and MRI, coupled with the rising prevalence of cancer, are major drivers for the CAD market. These improvements lead to more precise and higher-resolution images, allowing CAD software to perform more accurate analyses. Additionally, the shift towards cloud computing in healthcare has enabled the development of scalable and accessible CAD solutions that offer reduced IT costs and enhanced collaboration among healthcare providers. The trend towards multi-modality CAD systems, capable of analyzing images from various diagnostic equipment, further enhances diagnostic accuracy and patient outcomes.

The integration of AI in CAD systems marks a significant evolution in medical imaging, providing tools that learn from vast datasets to recognize complex patterns and anomalies indicative of diseases such as cancer. This AI integration speeds up diagnostics and reduces human error, aligning with the increasing emphasis on preventative healthcare and early diagnosis. Beyond general imaging, CAD systems find specialized applications in detecting conditions such as polyps in colonoscopy and lung nodules in pulmonology. Innovations in CAD are also making headways into digital pathology, with ongoing research expanding its applications beyond immunostaining to include broader diagnostic tasks such as analyzing standard H&E stains, highlighting its potential to significantly impact future medical practices.

Select Competitors (Total 103 Featured) -

  • Agfa-Gevaert NV
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi Ltd.
  • Hologic, Inc.
  • iCAD, Inc.
  • Invivo Corporation
  • Koninklijke Philips NV
  • McKesson Corporation
  • Merge Healthcare, Inc.
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Computer Aided Detection (CAD) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cancer Drives Computer Aided Detection Market Growth
    • Need for Early Disease Detection Spur Adoption of CAD
    • Integration of AI and Machine Learning in CAD Systems Throws Spotlight on Innovation
    • Expansion of Telemedicine and Remote Diagnostics Accelerates Market Growth
    • Increasing Demand for Automated Detection Solutions Drives Market Demand
    • Rising Investments in Cancer Research Expands Market Horizons
    • Growing Focus on Reducing Diagnostic Errors Spurs Adoption of CAD Systems
    • Increasing Use of CAD in Breast Cancer Screening Sustains Market Growth
    • Rising Demand for CAD in Lung Cancer Detection Here is the Story
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiovascular & Neurological Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cardiovascular & Neurological Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ultrasound Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ultrasound Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Tomosynthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Tomosynthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Imaging Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Imaging Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Computer Aided Detection (CAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Computer Aided Detection (CAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • JAPAN
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • CHINA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • EUROPE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Computer Aided Detection (CAD) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • GERMANY
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • INDIA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Computer Aided Detection (CAD) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Computer Aided Detection (CAD) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030
  • AFRICA
    • Computer Aided Detection (CAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Computer Aided Detection (CAD) by Application - Oncology and Cardiovascular & Neurological Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Application - Percentage Breakdown of Value Sales for Oncology and Cardiovascular & Neurological Indications for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Computer Aided Detection (CAD) by Imaging Modality - Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Computer Aided Detection (CAD) by Imaging Modality - Percentage Breakdown of Value Sales for Mammography, MRI, Ultrasound Imaging, Tomosynthesis, CT and Other Imaging Modalities for the Years 2014, 2024 & 2030

IV. COMPETITION